Skip to main content

Table 2 Outcome assessment

From: Leukocyte- and platelet-rich fibrin in endoscopic endonasal skull base reconstruction: study protocol for a multicenter prospective, parallel-group, single-blinded randomized controlled non-inferiority trial

Procedure

Visit 1

Screening

Visit 2

Allocation

Visit 3

FU1a

Visit 4

FU 2b

Visit 5

FU 3c

Visit 6

FU 4d

Enrolment

 Eligibility screening

X

     

 Informed consent

X

     

 Randomization

 

X

    

Interventions

 Endoscopic endonasal transsphenoidal surgery

 

X

    

 Sellar floor reconstruction/closure

 

X

    

Assessments

 Medical history

X

     

 EQ-5D

X

 

X

X

X

X

 VAS

X

 

X

X

X

X

 SNOT-22 questionnaire

X

 

X

X

X

X

 SBI

X

 

X

X

X

X

 MR imaging

X

   

X

X

 Cost/material

 

X

    

 Intraoperative CSF leakage

 

X

    

 Nasal endoscopy to assess CSF leakage

  

X

X

X

X

 Nasal endoscopy to assess wound healing

  

X

X

X

X

 Nasal endoscopy to assess infection

  

X

X

X

X

 Assessment of adverse events

 

X

X

X

X

X

  1. CSF cerebrospinal fluid, EQ-5D EuroQol-5D, SBI Skull Base Inventory, SNOT-22 Sino-Nasal Outcome Test with 22 items, FU follow-up, VAS visual analog scale
  2. a2 weeks postoperative
  3. b4 weeks postoperative
  4. c3 months postoperative
  5. d1 year postoperative